Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

2.

Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.

Murphy NC, Biankin AV, Millar EK, McNeil CM, O'Toole SA, Segara D, Crea P, Olayioye MA, Lee CS, Fox SB, Morey AL, Christie M, Musgrove EA, Daly RJ, Lindeman GJ, Henshall SM, Visvader JE, Sutherland RL.

Int J Cancer. 2010 Mar 15;126(6):1445-53. doi: 10.1002/ijc.24826.

3.

Prediction VO2max during cycle ergometry based on submaximal ventilatory indicators.

Nunes RA, Vale RG, Simão R, de Salles BF, Reis VM, Novaes Jda S, Miranda H, Rhea MR, Medeiros Ada C.

J Strength Cond Res. 2009 Sep;23(6):1745-51. doi: 10.1519/JSC.0b013e3181b45c49.

PMID:
19675488
4.

Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the Integrative Model of Behavioral Prediction: a cross-sectional study.

Schmid-Mohler G, Thut MP, Wüthrich RP, Denhaerynck K, De Geest S.

Clin Transplant. 2010 Mar-Apr;24(2):213-22. doi: 10.1111/j.1399-0012.2009.01056.x. Epub 2009 Aug 11.

PMID:
19674014
5.

Are scores useful in advanced heart failure?

Goldraich L, Beck-da-Silva L, Clausell N.

Expert Rev Cardiovasc Ther. 2009 Aug;7(8):985-97. doi: 10.1586/erc.09.68. Review.

PMID:
19673676
6.
7.

Prognostic role of plasma insulin-like growth factor (IGF) and IGF-binding protein 3 in metastatic colorectal cancer.

Garcia-Albeniz X, Gallego R.

Clin Cancer Res. 2009 Aug 15;15(16):5288; author reply 5288. doi: 10.1158/1078-0432.CCR-09-0635. Epub 2009 Aug 11. No abstract available.

8.

Validation of models that predict Cesarean section after induction of labor.

Verhoeven CJ, Oudenaarden A, Hermus MA, Porath MM, Oei SG, Mol BW.

Ultrasound Obstet Gynecol. 2009 Sep;34(3):316-21. doi: 10.1002/uog.7315.

9.

Which ultrasound or biochemical markers are independent predictors of small-for-gestational age?

Law LW, Leung TY, Sahota DS, Chan LW, Fung TY, Lau TK.

Ultrasound Obstet Gynecol. 2009 Sep;34(3):283-7. doi: 10.1002/uog.6455.

10.

Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation.

Massicotte L, Capitanio U, Beaulieu D, Roy JD, Roy A, Karakiewicz PI.

Transplantation. 2009 Aug 15;88(3):386-91. doi: 10.1097/TP.0b013e3181aed477.

PMID:
19667942
11.

Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.

Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM.

J Clin Oncol. 2009 Sep 10;27(26):4293-9. doi: 10.1200/JCO.2008.18.7047. Epub 2009 Aug 10.

PMID:
19667278
12.

Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.

Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H.

J Clin Oncol. 2009 Sep 10;27(26):4306-13. doi: 10.1200/JCO.2008.21.5228. Epub 2009 Aug 10.

13.

Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease.

Koenig W, Vossen CY, Mallat Z, Brenner H, Benessiano J, Rothenbacher D.

Eur Heart J. 2009 Nov;30(22):2742-8. doi: 10.1093/eurheartj/ehp302. Epub 2009 Aug 7.

PMID:
19666896
14.

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

Kosmider O, Gelsi-Boyer V, Cheok M, Grabar S, Della-Valle V, Picard F, Viguié F, Quesnel B, Beyne-Rauzy O, Solary E, Vey N, Hunault-Berger M, Fenaux P, Mansat-De Mas V, Delabesse E, Guardiola P, Lacombe C, Vainchenker W, Preudhomme C, Dreyfus F, Bernard OA, Birnbaum D, Fontenay M; Groupe Francophone des Myélodysplasies..

Blood. 2009 Oct 8;114(15):3285-91. doi: 10.1182/blood-2009-04-215814. Epub 2009 Aug 7.

15.

Model-based prediction of length of stay for rehabilitating stroke patients.

Lin CL, Lin PH, Chou LW, Lan SJ, Meng NH, Lo SF, Wu HD.

J Formos Med Assoc. 2009 Aug;108(8):653-62.

16.

Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer.

Monzon JG, Cremin C, Armstrong L, Nuk J, Young S, Horsman DE, Garbutt K, Bajdik CD, Gill S.

Int J Cancer. 2010 Feb 15;126(4):930-9. doi: 10.1002/ijc.24808.

17.

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.

Stinchcombe TE, Hodgson L, Herndon JE 2nd, Kelley MJ, Cicchetti MG, Ramnath N, Niell HB, Atkins JN, Akerley W, Green MR, Vokes EE; Cancer and Leukemia Group B..

J Thorac Oncol. 2009 Sep;4(9):1117-25. doi: 10.1097/JTO.0b013e3181b27b33.

18.

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P, Cortelazzo S, Martinelli G, Martelli M, Rigacci L, Arcaini L, Di Raimondo F, Merli F, Sabattini E, McLaughlin P, Solal-Céligny P.

J Clin Oncol. 2009 Sep 20;27(27):4555-62. doi: 10.1200/JCO.2008.21.3991. Epub 2009 Aug 3.

PMID:
19652063
19.

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Vickers AJ, Cronin AM, Elkin EB, Gonen M.

BMC Med Inform Decis Mak. 2008 Nov 26;8:53. doi: 10.1186/1472-6947-8-53.

20.

Assessing the value of risk predictions by using risk stratification tables.

Janes H, Pepe MS, Gu W.

Ann Intern Med. 2008 Nov 18;149(10):751-60.

Supplemental Content

Support Center